PROCESS INTERMECIATE FOR THE SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT METHYL (2S,3S,4R)-3-ETHYL-4-HYDROXPYRROLIDINE-2-CARBOXYLATE 4-METHYLBENZENESULFONATE.
PHYSICAL STATE: SOLID
COLOUR: WHITE TO OFF WHITE
PROCESS INTERMECIATE FOR THE SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT METHYL (2S,3S,4R)-3-ETHYL-4-HYDROXPYRROLIDINE-2-CARBOXYLATE 4-METHYLBENZENESULFONATE.
PHYSICAL STATE: SOLID
COLOUR: WHITE TO OFF WHITE
PROCESS INTERMECIATE FOR THE SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT METHYL (2S,3S,4R)-3-ETHYL-4-HYDROXPYRROLIDINE-2-CARBOXYLATE 4-METHYLBENZENESULFONATE.
PHYSICAL STATE: SOLID
COLOUR: WHITE TO OFF WHITE
Einreihungsbegründung
CLASSIFICATION IS DETERMINED BY THE PROVISIONS OF THE GENERAL RULES 1 AND 6 FOR THE INTERPRETATION OF THE COMBINED NOMENCLATURE;
THE TEXT OF CODES 2933 AND 2933 99 80,
THE HARMONISED SYSTEM EXPLANATORY NOTES TO HEADING 2933;
APPLICANTS DECLARATION ON THE BTI APPLICATION.
TARIFF SUSPENSION REGULATION (EU) 2017/1134.
Schlagwörter
CHEMICAL PRODUCTSFOR PHARMACEUTICAL INDUSTRYFOR PHARMACEUTICALSIN SOLID FORMMISCELLANEOUS PHARMACEUTICALSORGANIC COMPOUNDSWHITE